Kusajili – Clinical trials directory

Result of your search per sponsor: NovaCardia, Inc. (A wholly owned subsidiary of Merck & Co., Inc.)

Woman and Man Max 99 years
NovaCardia, Inc. (A wholly owned subsidiary of Merck & Co., Inc.) Update Il y a 5 ans

A multicenter, randomized, double-blind, placebo-controlled study of the hemodynamic effects of rolofylline injectable emulsion in the treatment of patients with heart failure The objectives of this study are to estimate the effects of rolofylline, alone in addition to loop diuretic therapy, on pulmonary capillary wedge pressure, as well as other hemodynamic parameters, and...

Country None
organs None
Specialty None

Closed trial

More information